ACCA Phosphopeptide Recognition by the BRCT Repeats of BRCA1

Journal of Molecular Biology

Volumn 359, Issue 4, 2006, Pages 973-982

  Ray, Hind ^a   Moreau, Karen ^a   Dizin, Eva ^a   Callebaut, Isabelle ^b   Venezia, Nicole Dalla ^a  

^a CNRS   (France)

^b UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

Author keywords

ACCA; BRCT; phosphopeptide; protein modelling; protein protein interaction

Indexed keywords

ALANYLCYSTEINYLCYSTEINYLALANINE; AMINO ACID; BRCA1 PROTEIN; GLUTATHIONE TRANSFERASE; PHOSPHOPEPTIDE; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; EXPERIMENTATION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GERM LINE; IMMUNOPRECIPITATION; MOLECULAR MODEL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SEQUENCE ANALYSIS; TANDEM REPEAT; TUMOR SUPPRESSOR GENE;

EID: 33744822528     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.04.010     Document Type: Article

References (52)

1. Narod S.A., and Foulkes W.D. BRCA1 and BRCA2: 1994 and beyond. Nature Rev. Cancer 4 (2004) 665-676
2. Rosen E.M., Fan S., Pestell R.G., and Goldberg I.D. BRCA1 gene in breast cancer. J. Cell Physiol. 196 (2003) 19-41
3. Koonin E.V., Altschul S.F., and Bork P. BRCA1 protein products...functional motifs. Nature Genet. 13 (1996) 266-268
4. Callebaut I., and Mornon J.P. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Letters 400 (1997) 25-30
5. Bork P., Hofmann K., Bucher P., Neuwald A.F., Altschul S.F., and Koonin E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11 (1997) 68-76
6. Couch F.J., and Weber B.L. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum. Mutat. 8 (1996) 8-18
7. Ludwig T., Fisher P., Ganesan S., and Efstratiadis A. Tumorigenesis in mice carrying a truncating Brca1 mutation. Genes Dev. 15 (2001) 1188-1193
8. Li S., Chen P.L., Subramanian T., Chinnadurai G., Tomlinson G., Osborne C.K., et al. Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J. Biol. Chem. 274 (1999) 11334-11338
9. Scully R., Chen J., Ochs R.L., Keegan K., Hoekstra M., Feunteun J., and Livingston D.M. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90 (1997) 425-435
10. Wong A.K., Ormonde P.A., Pero R., Chen Y., Lian L., Salada G., et al. Characterization of a carboxy-terminal BRCA1 interacting protein. Oncogene 17 (1998) 2279-2285
11. Yarden R.I., and Brody L.C. BRCA1 interacts with components of the histone deacetylase complex. Proc. Natl Acad. Sci. USA 96 (1999) 4983-4988
12. Yu X., Wu L.C., Bowcock A.M., Aronheim A., and Baer R. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273 (1998) 25388-25392
13. Cantor S.B., Bell D.W., Ganesan S., Kass E.M., Drapkin R., Grossman S., et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105 (2001) 149-160
14. Magnard C., Bachelier R., Vincent A., Jaquinod M., Kieffer S., Lenoir G.M., and Venezia N.D. BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains. Oncogene 21 (2002) 6729-6739
15. Yu X., Chini C.C., He M., Mer G., and Chen J. The BRCT domain is a phospho-protein binding domain. Science 302 (2003) 639-642
16. Manke I.A., Lowery D.M., Nguyen A., and Yaffe M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302 (2003) 636-639
17. Rodriguez M., Yu X., Chen J., and Songyang Z. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. J. Biol. Chem. 278 (2003) 52914-52918
18. Glover J.N., Williams R.S., and Lee M.S. Interactions between BRCT repeats and phosphoproteins: tangled up in two. Trends Biochem. Sci. 29 (2004) 579-585
19. Williams R.S., Lee M.S., Hau D.D., and Glover J.N. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Nature Struct. Mol. Biol. 11 (2004) 519-525
20. Clapperton J.A., Manke I.A., Lowery D.M., Ho T., Haire L.F., Yaffe M.B., and Smerdon S.J. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Nature Struct. Mol. Biol. 11 (2004) 512-518
21. Shiozaki E.N., Gu L., Yan N., and Shi Y. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling. Mol. Cell 14 (2004) 405-412
22. Botuyan M.V., Nomine Y., Yu X., Juranic N., Macura S., Chen J., and Mer G. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains. Structure (Camb.) 12 (2004) 1137-1146
23. Varma A.K., Brown R.S., Birrane G., and Ladias J.A. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex. Biochemistry 44 (2005) 10941-10946
24. Moreau K., Dizin E., Ray H., Luquain C., Lefai E., Foufelle F., et al. BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase. J. Biol. Chem 281 (2005) 3172-3181
25. McGuffin L.J., Bryson K., and Jones D.T. The PSIPRED protein structure prediction server. Bioinformatics 16 (2000) 404-405
26. Callebaut I., Labesse G., Durand P., Poupon A., Canard L., Chomilier J., et al. Deciphering protein sequence information through hydrophobic cluster analysis (HCA): current status and perspectives. Cell Mol. Life Sci. 53 (1997) 621-645
27. Yu X., and Chen J. DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains. Mol. Cell. Biol. 24 (2004) 9478-9486
28. Thoden J.B., Blanchard C.Z., Holden H.M., and Waldrop G.L. Movement of the biotin carboxylase B-domain as a result of ATP binding. J. Biol. Chem. 275 (2000) 16183-16190
29. Davies S.P., Sim A.T., and Hardie D.G. Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase. Eur. J. Biochem. 187 (1990) 183-190
30. Winder W.W., Wilson H.A., Hardie D.G., Rasmussen B.B., Hutber C.A., Call G.B., et al. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J. Appl. Physiol. 82 (1997) 219-225
31. Milgraum L.Z., Witters L.A., Pasternack G.R., and Kuhajda F.P. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin. Cancer Res. 3 (1997) 2115-2120
32. Kuhajda F.P., Pizer E.S., Li J.N., Mani N.S., Frehywot G.L., and Townsend C.A. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc. Natl Acad. Sci. USA 97 (2000) 3450-3454
33. Swinnen J.V., Vanderhoydonc F., Elgamal A.A., Eelen M., Vercaeren I., Joniau S., et al. Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int. J. Cancer 88 (2000) 176-179
34. Calle E.E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Rev. Cancer 4 (2004) 579-591
35. Bingham S., and Riboli E. Diet and cancer-the European Prospective Investigation into Cancer and Nutrition. Nature Rev. Cancer 4 (2004) 206-215
36. Pizer E.S., Jackisch C., Wood F.D., Pasternack G.R., Davidson N.E., and Kuhajda F.P. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res. 56 (1996) 2745-2747
37. Pizer E.S., Wood F.D., Heine H.S., Romantsev F.E., Pasternack G.R., and Kuhajda F.P. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res. 56 (1996) 1189-1193
38. De Schrijver E., Brusselmans K., Heyns W., Verhoeven G., and Swinnen J.V. RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res. 63 (2003) 3799-3804
39. Thupari J.N., Pinn M.L., and Kuhajda F.P. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochem. Biophys. Res. Commun. 285 (2001) 217-223
40. Zhou W., Simpson P.J., McFadden J.M., Townsend C.A., Medghalchi S.M., Vadlamudi A., et al. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res. 63 (2003) 7330-7337
41. Harwood Jr. H.J., Petras S.F., Shelly L.D., Zaccaro L.M., Perry D.A., Makowski M.R., et al. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J. Biol. Chem. 278 (2003) 37099-37111
42. Lee W.M., Elliott J.E., and Brownsey R.W. Inhibition of acetyl-CoA carboxylase isoforms by pyridoxal phosphate. J. Biol. Chem. 280 (2005) 41835-41843
43. Levert K.L., Waldrop G.L., and Stephens J.M. A biotin analog inhibits acetyl-CoA carboxylase activity and adipogenesis. J. Biol. Chem. 277 (2002) 16347-16350
44. Brusselmans K., De Schrijver E., Verhoeven G., and Swinnen J.V. RNA interference-mediated silencing of the acetyl-CoA-carboxylase-{alpha} gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res. 65 (2005) 6719-6725
45. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723
46. Schwede T., Kopp J., Guex N., and Peitsch M.C. SWISS-MODEL: an automated protein homology-modeling server. Nucl. Acids Res. 31 (2003) 3381-3385
47. Shen Y., Volrath S.L., Weatherly S.C., Elich T.D., and Tong L. A mechanism for the potent inhibition of eukaryotic acetyl-coenzyme A carboxylase by soraphen A, a macrocyclic polyketide natural product. Mol. Cell. 16 (2004) 881-891
48. Zhang H., Yang Z., Shen Y., and Tong L. Crystal structure of the carboxyltransferase domain of acetyl-coenzyme A carboxylase. Science 299 (2003) 2064-2067
49. Zhang H., Tweel B., Li J., and Tong L. Crystal structure of the carboxyltransferase domain of acetyl-coenzyme A carboxylase in complex with CP-640186. Structure (Camb.) 12 (2004) 1683-1691
50. Zhang H., Tweel B., and Tong L. Molecular basis for the inhibition of the carboxyltransferase domain of acetyl-coenzyme-A carboxylase by haloxyfop and diclofop. Proc. Natl Acad. Sci. USA 101 (2004) 5910-5915
51. Waldrop G.L., Rayment I., and Holden H.M. Three-dimensional structure of the biotin carboxylase subunit of acetyl-CoA carboxylase. Biochemistry 33 (1994) 10249-10256
52. Chajès V., Cambot M., Moreau K., Lenoir G.M., and Joulin V. Acetyl-coA carboxylase alpha is essential to breast cancer cell survival. Cancer Res (2006) In press